NASDAQ · ATEC
Healthcare · Medical - Devices
$9.48
Up+$0.19 (+2.05%)
Updated Aug 22, 2026, 9:50 AM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
ATEC closed at $9.48 after 21 trading sessions, up 14.77% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $9.26 | $9.505 | $9.11 | $9.48 | 1.45M |
| Aug 20, 2026 | $9.70 | $9.71 | $9.22 | $9.29 | 1.51M |
| Aug 19, 2026 | $9.53 | $10.00 | $9.50 | $9.75 | 1.54M |
| Aug 18, 2026 | $9.55 | $9.77 | $9.495 | $9.53 | 1.43M |
| Aug 17, 2026 | $9.63 | $9.75 | $9.35 | $9.45 | 1.4M |
| Aug 14, 2026 | $9.79 | $9.915 | $9.69 | $9.79 | 1.76M |
| Aug 13, 2026 | $9.74 | $9.81 | $9.54 | $9.75 | 1.19M |
| Aug 12, 2026 | $9.24 | $9.695 | $9.115 | $9.63 | 1.95M |
| Aug 11, 2026 | $9.47 | $9.68 | $9.34 | $9.37 | 1.46M |
| Aug 10, 2026 | $9.10 | $9.525 | $9.10 | $9.49 | 1.97M |
| Aug 7, 2026 | $9.335 | $9.335 | $9.045 | $9.31 | 2.41M |
| Aug 6, 2026 | $9.55 | $9.642 | $8.90 | $9.21 | 3.7M |
| Aug 5, 2026 | $9.87 | $10.10 | $9.26 | $9.57 | 5.22M |
| Aug 4, 2026 | $9.96 | $10.39 | $9.96 | $10.35 | 4.38M |
| Aug 3, 2026 | $9.998 | $10.30 | $9.86 | $10.15 | 4.59M |
| Jul 31, 2026 | $9.73 | $9.755 | $9.46 | $9.52 | 1.67M |
| Jul 30, 2026 | $9.65 | $9.795 | $9.535 | $9.66 | 1.81M |
| Jul 29, 2026 | $9.23 | $9.67 | $9.20 | $9.65 | 2.43M |
| Jul 28, 2026 | $9.10 | $9.425 | $8.9998 | $9.32 | 2.08M |
| Jul 27, 2026 | $8.42 | $8.89 | $8.42 | $8.67 | 1.79M |
| Jul 24, 2026 | $8.21 | $8.38 | $8.06 | $8.26 | 1.46M |
The latest Smart Investors Daily articles mentioning ATEC.
ATEC research
Company profile and research snapshot.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 5, 2026 | UBS | Buy | — |
| Aug 5, 2026 | TD Cowen | Buy | — |
| Aug 5, 2026 | BMO Capital | Outperform | — |
| Jul 28, 2026 | UBS | Buy | — |
| Jul 23, 2026 | Stephens & Co. | Overweight | — |
No generated briefing is available yet.
Yahoo · Jan 30, 2026
Alphatec Holdings Inc. (NASDAQ:ATEC) is one of the best high short interest stocks with biggest upside potential. On January 27, TD Cowen lowered its price target for Alphatec to $20 from $27 while maintaining a Buy rating following a transfer of coverage. The firm suggested that the current market expectations do not fully appreciate the […]
SeekingAlpha · Jan 25, 2026
SeekingAlpha · Jan 14, 2026
Alphatec Holdings, Inc. (ATEC) 44th Annual J.P.
SeekingAlpha · Jan 13, 2026
Alphatec Holdings, Inc. is rated Hold, continues to deliver strong top-line growth and operational leverage. Learn more about ATEC stock here.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ATEC.
